CC
CLBT icon

Centiva Capital’s Cellebrite CLBT Stock Holding History

Centiva Capital’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,058
Closed -$345K – 1880
2026
Q1 		$345K Buy
25,058
+14,216
+131% +$214K ﹤0.01% 1003
2025
Q4 		$195K Buy
+10,842
New +$195K ﹤0.01% 995
2025
Q1 		– Sell
-17,421
Closed -$384K – 1614
2024
Q4 		$384K Buy
+17,421
New +$335K 0.01% 991
2024
Q3 		– Sell
-162,177
Closed -$1.94M – 2193
2024
Q2 		$1.94M Buy
162,177
+107,570
+197% +$1.2M 0.03% 436
2024
Q1 		$605K Buy
54,607
+20,025
+58% +$204K 0.01% 900
2023
Q4 		$299K Buy
+34,582
New +$269K 0.01% 1202

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Centiva Capital's CLBT Position: Q2 2026 in Review

Centiva Capital sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 25,058 shares — an estimated $345K sold.

Centiva Capital first reported a position in CLBT in Q4 2023 and held it in 6 quarters. The position peaked at $1.94M in Q2 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Centiva Capital reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 25,058 Cellebrite shares in Q2 2026, an estimated $345K.
  • Centiva Capital first reported a position in Cellebrite in Q4 2023 and held it in 6 quarters.
  • Centiva Capital's Cellebrite position peaked at $1.94M in Q2 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.